Embecta
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 2.2K
- Market Cap
- -
- Introduction
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Embecta AID System in Adults With Type 2 Diabetes
Not Applicable
Withdrawn
- Conditions
- Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 DMT2DM With Inadequate Glycemic ControlT2DM (Type 2 Diabetes Mellitus)T2DT2DM
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Embecta Corp.
- Target Recruit Count
- 360
- Registration Number
- NCT06692153
- Locations
- 🇺🇸
Stanford, Palo Alto, California, United States
🇺🇸Diablo Research, Walnut Creek, California, United States
🇺🇸Indiana Universtiy School of Medicine, Indianapolis, Indiana, United States
© Copyright 2025. All Rights Reserved by MedPath